Effect of topical laurocapram (Azone®) on the in vitro percutaneous permeation of sodium lauryl sulfate using human skin

Acta Dermato-Venereologica

Volumn 76, Issue 3, 1996, Pages 182-185

  Szolar Platzer, C ^a   Patil, S ^a   Maibach, H I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

penetration enhancer; percutaneous penetration; skin irritancy; topical application

Indexed keywords

DODECYL SULFATE SODIUM; LAUROCAPRAM;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG PENETRATION; HUMAN; HUMAN TISSUE; IRRITANT DERMATITIS; PRIORITY JOURNAL; SKIN IRRITATION; SKIN PENETRATION; SKIN PERMEABILITY;

ADMINISTRATION, TOPICAL; AZEPINES; HUMANS; SKIN ABSORPTION; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS;

EID: 0030013905     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vaidyanathan R, Rajadhyaksha VJ, Kim BK, Anisko JJ. Azone. In: Kydonieus AF, Berner B, eds. Transdermal delivery of drugs. Vol II. Boca Raton: CRC Press, 1987: 63-83.
2. Schuckler F, Lee G. Relating the concentration-dependent action of Azone and dodecyl-L-pyroglutamate on the structure of excised human stratum corneum to changes in drug diffusivity, partition coefficient and flux. Int J Pharm 1992; 80: 81-89.
3. Faucher JA, Goddard ED. Interaction of keratinous substrates with sodium lauryl sulfate. I. Sorption J Soc Cosmet Chem 1978; 29: 323-337.
4. Froebe CL, Simion FA, Rhein LD, Cagan RH, Kligman A. Stratum corneum lipid removal by surfactants: relation to in vivo irritation. Dermatologica 1990; 181: 277-283.
5. Turunen TM, Urtti A, Paronen P, Audus KL, Rytting JH. Effect of some penetration enhancers on epithelial membrane lipid domains: evidence from fluorescence spectroscopy studies. Pharm Res 1994; 11: 288-294.
6. Sugibayashi S, Nakayama S, Seki T, Hosoyab KI, Morimoto Y. Mechanism of skin penetration-enhancing effect by laurocapram. J Pharm Sci 1992; 81: 58-64.
7. Engblom J, Engstrom S, Fontell K. The effect of the skin penetration enhancer Azone® on fatty acid-sodium soap-water mixtures. J Con Rel 1995; 33:299-305.
8. Schuckler F, Bouwstra JA, Gooris GS, Lee G. An X-ray diffraction study of some model stratum corneum lipids containing Azone® and dodecyl-L-pyroglutamate. J Con Rel 1993; 23: 27-36.
9. Engblom J, Engstrom S. Azone® and the formation of reversed mono- and bicontinuous lipid-water phases. Int J Pharm 1993; 98: 173-179.
10. Skelly JP, Maibach HI, Guy R, Wester C, Flynn G, Yacobi A. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. FDA/AAPS . 1987.
11. Kligman AM. Hydration injury to human skin. In: Elsner P, Berardesca E, Maibach HI, eds. Bioengineering of the skin: water and the stratum corneum. Boca Raton, Florida: CRC Press Inc., 1994: 243-247.
12. Bloom E, Sznitowska M, Polansky J, Ma ZD, Maibach HI. Increased proliferation of skin cells by sublethal doses of sodium lauryl sulfate. Dermatology 1994; 188: 263-268.
13. Lee CH, Maibach HI. The sodium lauryl sulfate model: an overview. Contact Dermatitis 1995;33: 1-7.
14. Wiechers JW, De Zeewuw RA. Transdermal drug delivery: efficacy and potential applications of the penetration enhancer Azone. Drug Design and Delivery 1990; 6: 87-100.
15. Willis IA. The effect of prolonged water exposure on human skin. J Invest Dermatol 1973; 60: 166-171.
16. Leveque JL. Water-keratin interactions. In: Elsner P, Berardesca E, Maibach HI, eds. Bioengineering of the skin: water and the stratum corneum. Boca Raton, Florida: CRC Press Inc., 1994: 11-20.
17. Stoughton RB. Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. Arch Dermatol 1982; 118: 474-477.
18. Bouwstra J, Peschier L, Brussee J, Bodde H. Effect of N-alkyl azocycloheptan-2-ones including Azone on thermal behaviour of human stratum corneum. Int J Pharm 1989; 52: 47-54.
19. Patil S, Singh P, Sarasour K, Maibach HI. Quantification of sodium lauryl sulfate (SLS) penetration into the skin and underlying tissues after topical application-pharmaceutical and toxicological implications. J Pharm Sci 1996; in press.
20. Rhein JD, Robbins CR, Fernee K, Cantore R. Surfactant structure effects on swelling of isolated human stratum corneum. J Soc Cosmet Chem 1986; 37: 125-139.
21. Leveque JL, De Rigal J, Saint-Leger D, Billy D. How does sodium lauryl sulfate alter the skin barrier function in man? A multiparametric approach. Skin Pharmacol 1993; 6: 111-115.
22. Ribaud C, Garson JC, Leveque JL. In vitro study of the barrier function of human stratum corneum in relation to the organization of intercellular lipids and their thermal properties. J Invest Dermatol 1991; 96: 617.
23. Wotton PK, Mollgaard B, Hadgraft J, Hoelgard A. Vehicle effect on topical drug delivery. III. Effect of Azone on the cutaneous permeation of metronidazole and propylene glycol. Int J Pharm 1985; 24: 19-26.
24. Wiechers JW, Drenth BFH, Jonkman JHG, De Zeeuw RA. Percutaneous absorption and elimination of the penetration enhancer Azone in humans. Pharm Res 1987; 4: 519-523.
25. Wester RC, Melendres J, Sedik L, Maibach HI. Percutaneous absorption of Azone following single and multiple doses to human volunteers. J Pharm Sci 1994; 83: 124-125.